Healthy volunteers help test new Drug's safety profile
NCT ID NCT06698926
First seen Jan 09, 2026 · Last updated May 20, 2026 · Updated 17 times
Summary
This early-stage study tested the safety and how the body processes a new drug called ABBV-CLS-616 in 110 healthy volunteers. Participants took single or multiple doses of the drug to check for side effects and how it interacts with food or other medicines. The goal was to gather essential safety information, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Acpru /Id# 270532
Grayslake, Illinois, 60030, United States
Conditions
Explore the condition pages connected to this study.